Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Gavan

Showing results (81-90 of 96) with videos related to

Pageof 10
Sort By:
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Journal of Clinical Microbiology|June 1, 1980
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical cardH D Isenberg, T L Gavan, P B Smith, et al.
The Journal of Antibiotics|September 1, 1979
Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidisP C Fuchs, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|July 1, 1986
Selection of a reference lot of Mueller-Hinton agarH M Pollock, A L Barry, T L Gavan, et al.
Journal of Clinical Microbiology|December 1, 1989
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracyclineR N Jones, T L Gavan, C Thornsberry, et al.
Annals of Internal Medicine|February 1, 1971
Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentrationM C McHenry, T L Gavan, R W Gifford, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testingL W Ayers, R N Jones, A L Barry, et al.
Pageof 10

Showing results (81-90 of 96) with videos related to

Sort By:
Pageof 10
Diagnostic Microbiology and Infectious Disease|May 1, 1987
Quality control limits for microdilution susceptibility tests with aztreonam, imipenem, ceftriaxone, ceftazidime, ceftizoxime, cefuroxime, and cefonicidA L Barry, T L Gavan, R N Jones, et al.
Diagnostic Microbiology and Infectious Disease|July 1, 1986
In vitro evaluation of cefixime (FK027, FR17027, CL284635): spectrum against recent clinical isolates, comparative antimicrobial activity, beta-lactamase stability, and preliminary susceptibility testing criteriaP C Fuchs, R N Jones, A L Barry, et al.
Diagnostic Microbiology and Infectious Disease|November 1, 1990
Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeR N Jones, P C Fuchs, J A Washington, et al.
Journal of Clinical Microbiology|June 1, 1980
Collaborative investigation of the AutoMicrobic System Enterobacteriaceae biochemical cardH D Isenberg, T L Gavan, P B Smith, et al.
The Journal of Antibiotics|September 1, 1979
Rosamicin: in vitro activity comparison with erythromycin and other antibiotics against clinical isolates from the genito-urinary tract and Neisseria meningitidisP C Fuchs, C Thornsberry, A L Barry, et al.
Antimicrobial Agents and Chemotherapy|July 1, 1980
Cefotaxime: in vitro activity and tentative interpretive standards for disk susceptibility testingP C Fuchs, A L Barry, C Thornsberry, et al.
Journal of Clinical Microbiology|July 1, 1986
Selection of a reference lot of Mueller-Hinton agarH M Pollock, A L Barry, T L Gavan, et al.
Journal of Clinical Microbiology|December 1, 1989
Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracyclineR N Jones, T L Gavan, C Thornsberry, et al.
Annals of Internal Medicine|February 1, 1971
Gentamicin dosages for renal insufficiency. Adjustments based on endogenous creatinine clearance and serum creatinine concentrationM C McHenry, T L Gavan, R W Gifford, et al.
Antimicrobial Agents and Chemotherapy|November 1, 1982
Cefotetan, a new cephamycin: comparison of in vitro antimicrobial activity with other cephems, beta-lactamase stability, and preliminary recommendations for disk diffusion testingL W Ayers, R N Jones, A L Barry, et al.
Pageof 10